These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36362298)

  • 1. Uremic Myopathy and Mitochondrial Dysfunction in Kidney Disease.
    Serrano E; Whitaker-Menezes D; Lin Z; Roche M; Martinez Cantarin MP
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease.
    Thome T; Kumar RA; Burke SK; Khattri RB; Salyers ZR; Kelley RC; Coleman MD; Christou DD; Hepple RT; Scali ST; Ferreira LF; Ryan TE
    JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5/6 nephrectomy models in mice.
    Kim K; Anderson EM; Thome T; Lu G; Salyers ZR; Cort TA; O'Malley KA; Scali ST; Ryan TE
    Am J Physiol Renal Physiol; 2021 Jul; 321(1):F106-F119. PubMed ID: 34121452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremic metabolites impair skeletal muscle mitochondrial energetics through disruption of the electron transport system and matrix dehydrogenase activity.
    Thome T; Salyers ZR; Kumar RA; Hahn D; Berru FN; Ferreira LF; Scali ST; Ryan TE
    Am J Physiol Cell Physiol; 2019 Oct; 317(4):C701-C713. PubMed ID: 31291144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.
    Enoki Y; Watanabe H; Arake R; Fujimura R; Ishiodori K; Imafuku T; Nishida K; Sugimoto R; Nagao S; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
    J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):735-747. PubMed ID: 28608457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Mitochondrial and Redox Alterations in the Skeletal Myopathy Associated with Chronic Kidney Disease.
    Thome T; Kim K; Dong G; Ryan TE
    Antioxid Redox Signal; 2023 Feb; 38(4-6):318-337. PubMed ID: 36245209
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of a high-throughput method for real-time assessment of cellular metabolism in intact long skeletal muscle fibre bundles.
    Li R; Steyn FJ; Stout MB; Lee K; Cully TR; Calderón JC; Ngo ST
    J Physiol; 2016 Dec; 594(24):7197-7213. PubMed ID: 27619319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tryptophan-derived uremic metabolite/Ahr/Pdk4 axis governs skeletal muscle mitochondrial energetics in chronic kidney disease.
    Thome T; Vugman NA; Stone LE; Wimberly K; Scali ST; Ryan TE
    JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38652558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle single fiber force production declines early in juvenile male mice with chronic kidney disease.
    Momb BA; Patino E; Akchurin OM; Miller MS
    Physiol Rep; 2023 Apr; 11(7):e15651. PubMed ID: 37020355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations to mitochondrial fatty-acid use in skeletal muscle after chronic exposure to hypoxia depend on metabolic phenotype.
    Malgoyre A; Chabert C; Tonini J; Koulmann N; Bigard X; Sanchez H
    J Appl Physiol (1985); 2017 Mar; 122(3):666-674. PubMed ID: 28035013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease exacerbates ischemic limb myopathy in mice via altered mitochondrial energetics.
    Berru FN; Gray SE; Thome T; Kumar RA; Salyers ZR; Coleman M; Dennis Le ; O'Malley K; Ferreira LF; Berceli SA; Scali ST; Ryan TE
    Sci Rep; 2019 Oct; 9(1):15547. PubMed ID: 31664123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin ameliorates CKD-induced mitochondrial dysfunction and oxidative stress through inhibiting GSK-3β activity.
    Wang D; Yang Y; Zou X; Zheng Z; Zhang J
    J Nutr Biochem; 2020 Sep; 83():108404. PubMed ID: 32531667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron Supplementation Improves Skeletal Muscle Contractile Properties in Mice with CKD.
    Momb BA; Patino E; Akchurin OM; Miller MS
    Kidney360; 2022 May; 3(5):843-858. PubMed ID: 36128477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease and acquired mitochondrial myopathy.
    Rao M; Jaber BL; Balakrishnan VS
    Curr Opin Nephrol Hypertens; 2018 Mar; 27(2):113-120. PubMed ID: 29266014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactose enhances oxidative metabolism and reveals mitochondrial dysfunction in human primary muscle cells.
    Aguer C; Gambarotta D; Mailloux RJ; Moffat C; Dent R; McPherson R; Harper ME
    PLoS One; 2011; 6(12):e28536. PubMed ID: 22194845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease.
    Gortan Cappellari G; Semolic A; Ruozi G; Vinci P; Guarnieri G; Bortolotti F; Barbetta D; Zanetti M; Giacca M; Barazzoni R
    FASEB J; 2017 Dec; 31(12):5159-5171. PubMed ID: 28778977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholic and deoxycholic acids induce mitochondrial dysfunction, impaired biogenesis and autophagic flux in skeletal muscle cells.
    Abrigo J; Olguín H; Tacchi F; Orozco-Aguilar J; Valero-Breton M; Soto J; Castro-Sepúlveda M; Elorza AA; Simon F; Cabello-Verrugio C
    Biol Res; 2023 Jun; 56(1):30. PubMed ID: 37291645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Aryl Hydrocarbon Receptor in Muscle Exacerbates Ischemic Pathology in Chronic Kidney Disease.
    Balestrieri N; Palzkill V; Pass C; Tan J; Salyers ZR; Moparthy C; Murillo A; Kim K; Thome T; Yang Q; O'Malley KA; Berceli SA; Yue F; Scali ST; Ferreira LF; Ryan TE
    Circ Res; 2023 Jul; 133(2):158-176. PubMed ID: 37325935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early mitochondrial dysfunction in glycolytic muscle, but not oxidative muscle, of the fructose-fed insulin-resistant rat.
    Warren BE; Lou PH; Lucchinetti E; Zhang L; Clanachan AS; Affolter A; Hersberger M; Zaugg M; Lemieux H
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E658-67. PubMed ID: 24425766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Bioenergetic and Proteomic Phenotyping Reveals Organ-Specific Consequences of Chronic Kidney Disease in Mice.
    Thome T; Coleman MD; Ryan TE
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.